Cargando…
Gankyrin is a predictive and oncogenic factor in well-differentiated and dedifferentiated liposarcoma
Liposarcoma is one of the most common histologic types of soft tissue sarcoma and is frequently an aggressive cancer with poor outcome. Hence, alternative approaches other than surgical excision are necessary to improve treatment of well-differentiated/dedifferentiated liposarcoma (WDLPS/DDLPS). For...
Autores principales: | Hwang, Ju-Ae, Yang, Heung-Mo, Hong, Doo-Pyo, Joo, Sung-Yeon, Choi, Yoon-La, Park, Joo-Hung, Lazar, Alexander J., Pollock, Raphael E., Lev, Dina, Kim, Sung Joo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4253419/ https://www.ncbi.nlm.nih.gov/pubmed/25238053 |
Ejemplares similares
-
The hepatocyte growth factor receptor as a potential therapeutic target for dedifferentiated liposarcoma
por: Bill, Kate Lynn J., et al.
Publicado: (2015) -
Analysis of the Intratumoral Adaptive Immune Response in Well Differentiated and Dedifferentiated Retroperitoneal Liposarcoma
por: Tseng, William W., et al.
Publicado: (2015) -
An experimental model for the study of well differentiated and dedifferentiated liposarcoma; deregulation of targetable tyrosine kinase receptors
por: Peng, Tingsheng, et al.
Publicado: (2010) -
AXL is a potential therapeutic target in dedifferentiated and pleomorphic liposarcomas
por: May, Caitlin D., et al.
Publicado: (2015) -
miR-133a function in the pathogenesis of dedifferentiated liposarcoma
por: Yu, Peter Y., et al.
Publicado: (2018)